Critical Comparison: United American Healthcare (OTCMKTS:UAHC) and ClearPoint Neuro (NASDAQ:CLPT)

United American Healthcare (OTCMKTS:UAHC) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation.

Risk and Volatility

United American Healthcare has a beta of -1.42, suggesting that its stock price is 242% less volatile than the S&P 500. Comparatively, ClearPoint Neuro has a beta of 0.89, suggesting that its stock price is 11% less volatile than the S&P 500.

Valuation & Earnings

This table compares United American Healthcare and ClearPoint Neuro’s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
United American Healthcare	N/A	N/A	N/A	N/A	N/A
ClearPoint Neuro	$23.95 million	6.25	-$22.09 million	($0.91)	-6.08

United American Healthcare has higher earnings, but lower revenue than ClearPoint Neuro.

Institutional and Insider Ownership

30.1% of ClearPoint Neuro shares are held by institutional investors. 14.3% of United American Healthcare shares are held by company insiders. Comparatively, 6.1% of ClearPoint Neuro shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares United American Healthcare and ClearPoint Neuro’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
United American Healthcare	N/A	N/A	N/A
ClearPoint Neuro	-92.21%	-83.94%	-47.92%

Analyst Ratings

This is a summary of recent ratings and target prices for United American Healthcare and ClearPoint Neuro, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
United American Healthcare	0	0	0	0	N/A
ClearPoint Neuro	0	0	3	0	3.00

ClearPoint Neuro has a consensus price target of $12.00, suggesting a potential upside of 117.00%. Given ClearPoint Neuro’s higher possible upside, analysts clearly believe ClearPoint Neuro is more favorable than United American Healthcare.

Summary

ClearPoint Neuro beats United American Healthcare on 5 of the 9 factors compared between the two stocks.

About United American Healthcare

United American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois.

About ClearPoint Neuro

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.